Global Mono-Ammonium Glycyrrhizinate Market Professional Survey Report 2019
SKU ID : QYR-14657657 | Publishing Date : 09-Sep-2019 | No. of pages : 117
Monoammonium glycyrrhizate is a white crystalline powder with a special sweet taste. With antibacterial anti-inflammatory, antiviral, anti-microbial, liver protection liver, throat cleaning teeth, antioxidant, inhibit melanin, high sweetness low heat energy, health effects. CAS:53956-04-0
The global Mono-Ammonium Glycyrrhizinate market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Mono-Ammonium Glycyrrhizinate volume and value at global level, regional level and company level. From a global perspective, this report represents overall Mono-Ammonium Glycyrrhizinate market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Mono-Ammonium Glycyrrhizinate in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Mono-Ammonium Glycyrrhizinate manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Tiansheng Pharmaceutical
Alps Pharmaceutical
Xinjiang Kunlunshengnong
Ruihong Bio-technique
ELION Group
Hunan Dinuo Pharmaceutical
Minophagen Pharmaceutical
Xinjiang TIANSHAN Pharmaceuticals Industry
Shaanxi Fujie Pharmaceutical
FAME Pharmaceuticals Industry
MAFCO Worldwide
Fanzhi Group
Qingdao Taitong Pharmaceutical
Cokey
Lion Corporation
Gansu Yalan Pharmaceutical
Greenline Biotech
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
High Purity
Low Purity
Segment by Application
Pharmaceuticals
Cosmetic
Food Industry
Others
The global Mono-Ammonium Glycyrrhizinate market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Mono-Ammonium Glycyrrhizinate volume and value at global level, regional level and company level. From a global perspective, this report represents overall Mono-Ammonium Glycyrrhizinate market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Mono-Ammonium Glycyrrhizinate in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Mono-Ammonium Glycyrrhizinate manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Tiansheng Pharmaceutical
Alps Pharmaceutical
Xinjiang Kunlunshengnong
Ruihong Bio-technique
ELION Group
Hunan Dinuo Pharmaceutical
Minophagen Pharmaceutical
Xinjiang TIANSHAN Pharmaceuticals Industry
Shaanxi Fujie Pharmaceutical
FAME Pharmaceuticals Industry
MAFCO Worldwide
Fanzhi Group
Qingdao Taitong Pharmaceutical
Cokey
Lion Corporation
Gansu Yalan Pharmaceutical
Greenline Biotech
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
High Purity
Low Purity
Segment by Application
Pharmaceuticals
Cosmetic
Food Industry
Others
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.